Givaudan, a Swiss manufacturer of flavours, fragrances and active cosmetic ingredients, has acquired a 25% stake in B. Kolormakeup & Skincare, an Italy-based company specialized in developing and producing end to end products in make-up and
Heuking Kühn Lüer Wojtek acted as legal counsel to Prose Group on the sale of its testing division, based in Germany and Switzerland, to Germany-based Tüv Süd, for an undisclosed consideration. &
Niederer Kraft Frey acted as legal counsel to Macquarie Group Limited on the offering of its CHF 320 million 0.395 percent bond due 2028. The bond is listed on SIX Swiss Exchange and represents Macquarie’s first group
Kuehne & Nagel International, a Switzerland-based provider of transport, logistics and supply chain management solutions, enters into a binding agreement to acquire 100% of the shares in Salmosped. The Oslo-based company is a Norwegian perishables freight
Switzerland based Dietrich Engineering Consultants has announced the acquisition of UK based Biotech and pharmaceutical system provider, Extract Technology, from Wabash National Corp, a U.S. listed trailer manufacturing company. The acquisition included Extract Technology
Switzerland-based global private markets firm, Partners Group, has, on behalf of its clients, agreed to acquire Pharmathen, a Greece-based pharmaceutical company, from international U.S. based investment firm BC Partners. The transaction values Pharmathen at
Ermenegildo Zegna Group, the privately-held Italian fashion company, will go public on the New York Stock Exchange later this year by way of a merger with Investindustrial Acquisition Corp., a special purpose acquisition corporation – or
The 2021 edition of the Legalcommunity Italian Awards 2021 took place in Rome, at the Casina di Macchia Madama. During the evening the protagonists, including firms and professionals, of legal and tax consultancy operating throughout the national
International hotel group Meininger manages its successful market entry in Switzerland and opens new hotels in Zürich Greencity (174 rooms, 582 beds) and Genève Centre Charmilles (104 rooms, 362 beds). Vischer advises Meininger on any Swiss
Kuros Biosciences, a bone graft technologies company, has entered into a royalty purchase agreement with Xoma Corporation, under which Xoma has purchased a proportion of the potential future pre-commercial milestone payments and all the potential
